XClinical’s “MARVIN4KIDS” at the DIA Geneva
XClinical presents the initiative “MARVIN4KIDS” at the DIA Annual EuroMeeting in Geneva
(firmenpresse) - XClinical GmbH, Munich, Germany – March 25, 2011 – XClinical, a European vendor of innovative software products for eClinical trials known for its innovative and user-friendly CDISC ODM-certified EDC software suite MARVIN, presents the initiative “MARVIN4KIDS” for the first time at the DIA Annual EuroMeeting in Geneva. The conference takes place from March 28 to 30.
“MARVIN4KIDS”
MARVIN4KIDS is an XClinical initiative to support child cancer care in cooperation with SIOP (International Society of Paediatric Oncology). XClinical has already been active in the area of child cancer research for several years already. The company has supported the GPOH (Society of Paediatric Oncology and Haematology) by providing a MARVIN licence at reduced costs. In SIOP XClinical has found an excellent partner sharing the belief, that in order to make better treatment possible it is necessary to invest energy, time and money in child cancer research and child cancer care. XClinical committed itself to donating 10,000€ to SIOP by the end of 2012. From March 2011 onwards XClinical will present the “MARVIN4KIDS” initiative at large clinical data management conferences. “We intend to make MARVIN4KIDS a real success for SIOP and XClinical. By supporting SIOP financially and by making more patients, families, doctors and researchers aware of SIOP’s great work, we hope to contribute to a future with excellent child cancer treatment. Thus we will frequently communicate this initiative to the clinical research community,” says Dr. Philippe Verplancke, CEO of XClinical.
SIOP’s vision
SIOP has a vision that no child should die of cancer. To achieve this vision SIOP is committed to ensuring that each child and young adult with cancer has access to state-of-the-art treatment and care. Each year, more than 160,000 children worldwide are diagnosed with cancer while an estimated 90,000 die from the disease.
SIOP President Gabriele Calaminus notes: “Targeted scientific research and universal access to care and support for children and young adults with cancer must be made public health priorities in all countries, and now. SIOP is grateful for XClinical’s commitment to both support SIOP financially and to help raise awareness that through SIOP, doctors and researchers can make a real difference to the life of tomorrow’s child” says SIOP President Gabriele Calaminus.
Visit XClinical at booth No. 1220 to learn more about “MARVIN4KIDS” and SIOP.
Highlights at booth No. 1220
But there are more reasons for visiting booth No. 1220 besides the “MARVIN4KIDS” initiative. XClinical’s experts will be available during the exhibition for detailed discussions on CDISC-based tools for the end-to-end eClinical process such as the company’s EDC system MARVIN and the eCRF design tool STUDY COMPOSER. A special topic will be the IWR/IVR system ID-netTM developed by the Belgian CRO IDDI, now providing an interface to MARVIN.
For the first time ever XClinical will also host a Tuesday Networking Reception. On Monday and Tuesday vouchers for refreshments are available at the XClinical booth
About SIOP
Established in 1969, the International Society of Paediatric Oncology (SIOP), with over 1500 members and a presence in over 100 countries, is the leading global professional society dedicated to children and young people who have cancer.
SIOP’s vision is that no child should die of cancer. To achieve this vision SIOP are committed to ensuring that each child and young adult with cancer has access to state of the art treatment and care. Through its annual congress SIOP plays its part in ensuring that the field of childhood cancer does not stand still, at the annual SIOP congress the outcomes of the best child cancer research and care are discussed.
Dr. Gabriele Calaminus is the President of SIOP. SIOP is governed by a board of directors and has its headquarters in Geneva, Switzerland.
Ira Hajdamacha, SIOP Office, Phone: +41 (0) 22 906 91 69
Email: irah(at)kenes.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.
XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM).
Katharina Lang, XClinical GmbH, Phone: +49 (0)89 / 45 22 77 – 52 20,
Email: press(at)xclinical.com
Datum: 25.03.2011 - 11:46 Uhr
Sprache: Deutsch
News-ID 1022450
Anzahl Zeichen: 0
contact information:
Contact person: Katharina Lang
Town:
Munich
Phone: +49 / (0)89 / 4522775000
Kategorie:
Computer & Software
Anmerkungen:
Diese Pressemitteilung wurde bisher 348 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"XClinical’s “MARVIN4KIDS” at the DIA Geneva
"
steht unter der journalistisch-redaktionellen Verantwortung von
XClinical GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
